Amikacin

Active ingredient description

Amikacin is an antibiotic used for a number of bacterial infections. Amikacin works by blocking the function of the bacteria’s 30S ribosomal subunit, making it unable to produce proteins.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Amikacin
D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06A Antibiotics for topical use → D06AX Other antibiotics for topical use
Discover more medicines within D06AX12
Amikacin
J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides
Discover more medicines within J01GB06
Amikacin
S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA21

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Structured Product Labeling (SPL/PLR)
US
Summary of Product Characteristics (SPC)
UK

Medicines

Amikacin is the active ingredient of these drugs:

Drug
Countries

Ecuador

Turkey

Brazil

Turkey

Cyprus

Austria

Turkey

Turkey

Turkey

Hong Kong United Kingdom

Romania Turkey

Hong Kong

Austria Estonia Finland Ireland Lithuania

Lithuania Poland

Italy

Ecuador

Turkey

Hong Kong Italy

Italy

Tunisia

Italy

Turkey

Italy

Hong Kong

Turkey

Cyprus Estonia Hong Kong

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₂₂H₄₃N₅O₁₃
Molecular mass: 585.603 g/mol

External identifiers

CAS Substance: 37517-28-5
CAS Substance: 39831-55-5
DrugBank Drug: DB00479
KEGG Drug: D02543
PubChem Compound: 37768
RxNorm Ingredient: 641
SNOMED-CT Concept: 387266001
Amikacin (substance)
UNII Identifier: 84319SGC3C
AMIKACIN